A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid…
Coal remains the largest source of electricity generation in the world. At the heart of Frontieras’s FASForm technology is a…
Researchers at Johns Hopkins may have found a new approach to group 3 medulloblastoma, a deadly and hard-to-treat pediatric brain cancer. Mouse…
A clinical trial in Brazil has found that adding a daily vitamin D supplement to standard chemotherapy improved outcomes for women with…
Quantum computing has long been described as a technology perpetually a decade away from practical relevance. However, recent advancements in the technology…
Researchers at Brown University Health have identified a molecule that could potentially alter how glioblastoma responds to treatment. Glioblastoma is…
A personalized mRNA vaccine has shown signs of meaningfully extending survival in pancreatic cancer patients. Six-year results from a small but…
Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That…
Targeted cancer therapies are increasingly being paired with immunotherapy and chemotherapy to improve outcomes across multiple tumor types First-in-class PP2A…
Frontieras notes milestone moment: groundbreaking of facility based on a new industrial model built on extracting the full value of…